valine has been researched along with Hyperlipemia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palmer, OM; Rhoads, DD; Sivak, RA | 1 |
| Bandsma, RH; Boer, T; Kuipers, F; Prinsen, BH; Rake, JP; Reijngoud, DJ; Smit, GP; van Der Velden, Mde S | 1 |
| Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kitabata, H; Kuroi, A; Mochizuki, S; Muragaki, Y; Takarada, S; Tanimoto, T; Tsujioka, H; Yoshida, K | 1 |
| Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kobayashi, K; Kuroi, A; Mochizuki, S; Muragaki, Y; Shiomi, M; Tsujioka, A; Tsujioka, H; Yoshida, K | 1 |
| Li, Z; Liu, J; Luo, CH; Tan, ZR; Wang, A; Wang, LS; Yu, BN; Zhang, W; Zhou, G; Zhou, HH | 1 |
| Endo, K; Koide, N; Miyashita, Y; Murano, T; Ohira, M; Oyama, T; Saiki, A; Shirai, K | 1 |
| Glazer, R; Jia, Y; Kariisa, M; Pitt, B; Prescott, MF; Radauceanu, A; Rajagopalan, S; Zannad, F | 1 |
| Hevia, P; Kari, FW; Ulman, EA; Visek, WJ | 1 |
| Barrett, HA; de Sain-van der Velden, MG; Gadellaa, MM; Kaysen, GA; Rabelink, TJ; Reijngoud, DJ; Stellaard, F; Voorbij, HA | 1 |
| Cameron, IM; Gaffney, D; Hoffs, MS; O'Reilly, DS; Packard, CJ; Stewart, G | 1 |
4 trial(s) available for valine and Hyperlipemia
| Article | Year |
|---|---|
Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.
Topics: Acetates; Adult; Case-Control Studies; Cholesterol; Female; Glycerol; Glycogen Storage Disease Type I; Humans; Hyperlipidemias; Infusions, Parenteral; Kinetics; Lipogenesis; Lipoproteins, IDL; Lipoproteins, VLDL; Male; Particle Size; Valine | 2008 |
Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.
Topics: Adult; Aged; Asian People; China; Cholesterol; Cortisone; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Gene Frequency; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Isoleucine; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Simvastatin; Triglycerides; Valine | 2005 |
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Hypertension; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2006 |
Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
Topics: Antihypertensive Agents; Biomarkers; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Chemokine CCL2; Double-Blind Method; Drug Combinations; Drug Synergism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Simvastatin; Tetrazoles; Valine; Valsartan | 2007 |
6 other study(ies) available for valine and Hyperlipemia
| Article | Year |
|---|---|
Plasma abnormalities following overdose.
Topics: Color; Diltiazem; Drug Overdose; Fat Emulsions, Intravenous; Female; Food-Drug Interactions; Hemolysis; Humans; Hyperlipidemias; Middle Aged; Off-Label Use; Plasma; Poisoning; Tetrazoles; Valine; Valsartan | 2014 |
Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.
Topics: Acetylcholine; Amides; Animals; Antihypertensive Agents; Atherosclerosis; Biopterins; Blood Pressure; Drug Therapy, Combination; Endothelium, Vascular; Fumarates; Heart Rate; HSP90 Heat-Shock Proteins; Hyperlipidemias; Inflammation Mediators; Lipids; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rabbits; Renin; Tetrazoles; Tyrosine; Valine; Valsartan; Vasodilation; Vasodilator Agents | 2008 |
Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Biological Availability; Drug Therapy, Combination; Echocardiography; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Myocardial Infarction; Nitric Oxide; Quinolines; Rabbits; Reactive Oxygen Species; Tetrazoles; Tyrosine; Valine; Valsartan | 2008 |
Serum lipids of rats fed excess L-lysine and different carbohydrates.
Topics: Amino Acids; Animals; Cholesterol; Dietary Carbohydrates; Dose-Response Relationship, Drug; Fatty Liver; Glutamates; Hyperlipidemias; Lipid Metabolism; Lipids; Liver; Lysine; Male; Phospholipids; Rats; Threonine; Triglycerides; Valine | 1980 |
Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
Topics: Adult; Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Carbon Isotopes; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Hyperlipidemias; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Serum Albumin; Valine | 1998 |
Influence of polymorphism Q3405E and mutation A3371V in the apolipoprotein B gene on LDL receptor binding.
Topics: Adult; Aged; Alanine; Amino Acid Substitution; Apolipoproteins B; DNA; DNA Mutational Analysis; Family; Family Health; Female; Gene Frequency; Glutamic Acid; Glutamine; Haplotypes; Humans; Hyperlipidemias; Leucine; Lipoproteins, LDL; Male; Middle Aged; Point Mutation; Polymorphism, Genetic; Protein Binding; Receptors, LDL; Valine | 1998 |